Arvinas, Inc. (ARVN)
Arvinas Market Cap: 809.23M for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pfizer Inc. | 147.20B |
| Alnylam Pharmaceuticals, Inc. | 48.28B |
| Verastem, Inc. | 479.03M |
| Genprex, Inc. | 2.842M |
| Olema Pharmaceuticals, Inc. | 1.805B |
Market Cap Related Metrics
| PS Ratio | 2.935 |
| Price to Book Value | 1.434 |
| Price | 12.60 |
| Earnings Yield | -6.37% |